4/12
08:00 am
XENE
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $62.00 price target on the stock.
Medium
Report
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $62.00 price target on the stock.
4/12
07:02 am
XENE
Rating for XENE
Medium
Report
Rating for XENE
4/12
07:02 am
XENE
Rating for XENE
Medium
Report
Rating for XENE
4/10
10:19 am
XENE
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Low
Report
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
4/10
09:46 am
XENE
Rating for XENE
Low
Report
Rating for XENE
3/1
10:44 am
XENE
Rating for XENE
Low
Report
Rating for XENE
3/1
10:44 am
XENE
Rating for XENE
Low
Report
Rating for XENE
3/1
08:40 am
XENE
Rating for XENE
Medium
Report
Rating for XENE
3/1
08:40 am
XENE
Rating for XENE
Medium
Report
Rating for XENE
3/1
08:10 am
XENE
Rating for XENE
Medium
Report
Rating for XENE
3/1
08:10 am
XENE
Rating for XENE
Medium
Report
Rating for XENE